First Affirmative Financial Network’s Regeneron Pharmaceuticals REGN Stock Holding History

First Affirmative Financial Network’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$241K	Buy	+317	New	+$240K	0.05%	339
2025 Q1	–	Sell	-288	Closed	-$205K	–	289
2024 Q4	$205K	Buy	288 +64	+29%	+$53.7K	0.12%	234
2024 Q3	$236K	Buy	224 +20	+10%	+$22.3K	0.13%	217
2024 Q2	$214K	Buy	+204	New	+$198K	0.15%	213

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.8B AUM 9.05% 1-Year Est. Return

LMCG Investments Boston, Massachusetts $1.86B AUM 40.01% 1-Year Est. Return

First Affirmative Financial Network's REGN Position: Q3 2026 in Review

First Affirmative Financial Network opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 317 shares worth $241K. The stake represents 0.05% of the portfolio and ranks #339 among its holdings. This is a return to the name: First Affirmative Financial Network previously reported a position in REGN as recently as Q4 2024.

First Affirmative Financial Network first reported a position in REGN in Q2 2024 and has held it in 4 quarters since. 333 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

First Affirmative Financial Network held 317 shares of Regeneron Pharmaceuticals worth $241K as of Q3 2026.
Regeneron Pharmaceuticals was a new First Affirmative Financial Network position in Q3 2026.
Regeneron Pharmaceuticals made up 0.05% of First Affirmative Financial Network's portfolio in Q3 2026, its #339 holding.
First Affirmative Financial Network first reported a position in Regeneron Pharmaceuticals in Q2 2024 and has held it in 4 quarters since.
333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on First Affirmative Financial Network's 13F filing for Q3 2026, filed 21 Oct 2026.